<i>Candida albicans</i> disorder is associated with gastric carcinogenesisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the fungal microbiome (mycobiome) in gastric cancer, using ITS rDNA gene sequencing to compare fungal communities between cancer lesions and adjacent noncancerous stomach tissue. Researchers analyzed operational taxonomic units (OTUs) and performed species identification, alpha and beta diversity analyses, and FUNGuild functional annotation. The goal was to characterize how fungal composition and ecology differ in gastric cancer tissue and to identify potential fungal biomarkers.
Who was studied?
The study drew on tissue samples from 45 gastric cancer cases collected in Shenyang, China. Each case contributed paired samples: a cancer lesion and adjacent noncancerous tissue, allowing within-patient comparison. No further demographic details (age, sex distribution) are given in the abstract.
What were the most important findings?
Gastric cancer tissue showed a significant fungal imbalance compared to noncancerous tissue, with principal component analysis revealing separate clusters for the two groups and lower overall OTU abundance in the cancer group. At the genus level, 15 fungal biomarkers distinguished the groups: Candida and Alternaria were enriched in gastric cancer, while Saitozyma and Thermomyces were decreased. Using both Welch's t test and the Wilcoxon rank sum test, Candida albicans was confirmed as significantly elevated in gastric cancer tissue.
What are the greatest implications of this study?
These findings support a role for nonbacterial, fungal components, particularly Candida albicans, in gastric carcinogenesis, an angle that has been underexplored relative to bacterial infection. The identification of specific fungal genera as biomarkers suggests the mycobiome could eventually contribute to diagnostic or risk-stratification tools for gastric cancer. The results also point to Candida albicans overgrowth as a feature worth investigating further as either a marker of, or contributor to, the tumor microenvironment.